BlackRock Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BlackRock Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$914K	Buy	9,877 +51	+0.5%	+$5.75K	﹤0.01%	2745
2016 Q3	$1.33M	Buy	9,826 +703	+8%	+$69.8K	﹤0.01%	2476
2016 Q2	$924K	Buy	9,123 +1,224	+15%	+$152K	﹤0.01%	2689
2016 Q1	$1.29M	Buy	7,899 +126	+2%	+$25.5K	﹤0.01%	2313
2015 Q4	$2.55M	Buy	7,773 +41	+0.5%	+$13.3K	﹤0.01%	1906
2015 Q3	$2.49M	Sell	7,732 -126	-2%	-$55.4K	﹤0.01%	1909
2015 Q2	$3.13M	Buy	7,858 +1,401	+22%	+$595K	﹤0.01%	1870
2015 Q1	$3.18M	Buy	6,457 +117	+2%	+$45.3K	﹤0.01%	1703
2014 Q4	$2.27M	Sell	6,340 -71	-1%	-$21.1K	﹤0.01%	1935
2014 Q3	$1.24M	Buy	6,411 +49	+0.8%	+$10.8K	﹤0.01%	2362
2014 Q2	$1.52M	Buy	6,362 +754	+13%	+$153K	﹤0.01%	2302
2014 Q1	$1.43M	Buy	5,608 +418	+8%	+$128K	﹤0.01%	2260
2013 Q4	$1.03M	Sell	5,190 -122	-2%	-$21.7K	﹤0.01%	2495
2013 Q3	$898K	Buy	5,312 +355	+7%	+$57.1K	﹤0.01%	2525
2013 Q2	$880K	Buy	+4,957	New	+$702K	﹤0.01%	2466

Other funds holding LUMO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's LUMO Position: Q4 2016 in Review

BlackRock Investment Management increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 0.52% in Q4 2016, buying an estimated $5.75K and bringing the position to 9,877 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

BlackRock Investment Management first reported a position in LUMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.18M in Q1 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

BlackRock Investment Management held 9,877 shares of Lumos Pharma, Inc. Common Stock worth $914K as of Q4 2016.
BlackRock Investment Management bought 51 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $5.75K.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2745 holding.
BlackRock Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $3.18M in Q1 2015.
122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.